Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study for Repurposing RET Inhibitors for Treating Cancer Cachexia

NCT07146893 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT07146893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07146893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study for Repurposing RET Inhibitors for Treating Cancer Cachexia
Lead sponsor
University of Oklahoma
Phase
Phase 1
Overall status
Not yet recruiting
Start date
February 26, 2026
Completion date
February 23, 2028
Enrollment
7 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia-anorexia syndrome